BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System
Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.BIOVECTRA and...